Matis Louis 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Feb 28, 2019
Insider Transaction Report
Form 4
Matis Louis
SVP, Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-02-26+96,500→ 96,500 totalExercise: $3.09Exp: 2029-02-26→ Common Stock (96,500 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on February 26, 2020 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.